TY  - CONF

T1  - 383 Integrated safety analysis of abrocitinib in 635 adolescent patients with moderate-to-severe atopic dermatitis with over 1000 patient-years of exposure

JO  - British Journal of Dermatology

UR  - http://dx.doi.org/10.1093/bjd/ljad162.011

PY  - 2023/06/20

AU  - Paller AS

AU  - Eichenfield LF

AU  - Silverberg JI

AU  - Cork MJ

AU  - Bangert C

AU  - Irvine AD

AU  - Weidinger S

AU  - Barbarot S

AU  - Fan H

AU  - Alderfer J

AU  - Koppensteiner H et al

ED  - 

DO  - DOI: 10.1093/bjd/ljad162.011

PB  - Oxford University Press (OUP)

VL  - 188

IS  - Supplement_3

Y2  - 2024/12/22

ER  -